Cargando…
The BET-bromodomain inhibitor JQ1 renders neuroblastoma cells more resistant to NK cell-mediated recognition and killing by downregulating ligands for NKG2D and DNAM-1 receptors
Low expression of ligands for NK cell-activating receptors contributes to neuroblastoma (NB) aggressiveness. Recently, we demonstrated that the expression of MYCN, a poor prognosis marker in NB, inversely correlates with that of activating ligands. This indicates that MYCN expression level can predi...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481332/ https://www.ncbi.nlm.nih.gov/pubmed/31040907 http://dx.doi.org/10.18632/oncotarget.26736 |
_version_ | 1783413753628327936 |
---|---|
author | Veneziani, Irene Fruci, Doriana Compagnone, Mirco Pistoia, Vito Rossi, Paolo Cifaldi, Loredana |
author_facet | Veneziani, Irene Fruci, Doriana Compagnone, Mirco Pistoia, Vito Rossi, Paolo Cifaldi, Loredana |
author_sort | Veneziani, Irene |
collection | PubMed |
description | Low expression of ligands for NK cell-activating receptors contributes to neuroblastoma (NB) aggressiveness. Recently, we demonstrated that the expression of MYCN, a poor prognosis marker in NB, inversely correlates with that of activating ligands. This indicates that MYCN expression level can predict the susceptibility of NB cells to NK cell-mediated immunotherapy and that its downregulation can be exploited as a novel therapeutic strategy to induce the expression of activating ligands. Here we evaluated the effect of the BET-bromodomain inhibitor JQ1 on the expression of ligands for NK cell-activating receptors in NB cell lines. Although downmodulating MYCN, JQ1 impaired the expression of ligands for NK cell-activating receptors, rendering NB cell lines more resistant to NK cell-mediated killing. The downregulation of activating ligands was due to JQ1-mediated impaired functions of both c-MYC and p53, two transcription factors known to regulate the expression of ULBP1-3 ligands for NKG2D activating receptor. Moreover JQ1 strongly downregulated the levels of ROS, a stress-induced signaling event associated with the induction of ligands for NK cell-activating receptors. These results suggest that the use of JQ1 should be discourage in combination with NK cell-based immunotherapy in a perspective chemotherapeutic treatment of NB. Thus, further investigations, exploiting molecular strategies aimed to boost the NK cell-mediated killing of NB cells, are warranted. |
format | Online Article Text |
id | pubmed-6481332 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-64813322019-04-30 The BET-bromodomain inhibitor JQ1 renders neuroblastoma cells more resistant to NK cell-mediated recognition and killing by downregulating ligands for NKG2D and DNAM-1 receptors Veneziani, Irene Fruci, Doriana Compagnone, Mirco Pistoia, Vito Rossi, Paolo Cifaldi, Loredana Oncotarget Research Paper Low expression of ligands for NK cell-activating receptors contributes to neuroblastoma (NB) aggressiveness. Recently, we demonstrated that the expression of MYCN, a poor prognosis marker in NB, inversely correlates with that of activating ligands. This indicates that MYCN expression level can predict the susceptibility of NB cells to NK cell-mediated immunotherapy and that its downregulation can be exploited as a novel therapeutic strategy to induce the expression of activating ligands. Here we evaluated the effect of the BET-bromodomain inhibitor JQ1 on the expression of ligands for NK cell-activating receptors in NB cell lines. Although downmodulating MYCN, JQ1 impaired the expression of ligands for NK cell-activating receptors, rendering NB cell lines more resistant to NK cell-mediated killing. The downregulation of activating ligands was due to JQ1-mediated impaired functions of both c-MYC and p53, two transcription factors known to regulate the expression of ULBP1-3 ligands for NKG2D activating receptor. Moreover JQ1 strongly downregulated the levels of ROS, a stress-induced signaling event associated with the induction of ligands for NK cell-activating receptors. These results suggest that the use of JQ1 should be discourage in combination with NK cell-based immunotherapy in a perspective chemotherapeutic treatment of NB. Thus, further investigations, exploiting molecular strategies aimed to boost the NK cell-mediated killing of NB cells, are warranted. Impact Journals LLC 2019-03-15 /pmc/articles/PMC6481332/ /pubmed/31040907 http://dx.doi.org/10.18632/oncotarget.26736 Text en Copyright: © 2019 Veneziani et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (http://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Veneziani, Irene Fruci, Doriana Compagnone, Mirco Pistoia, Vito Rossi, Paolo Cifaldi, Loredana The BET-bromodomain inhibitor JQ1 renders neuroblastoma cells more resistant to NK cell-mediated recognition and killing by downregulating ligands for NKG2D and DNAM-1 receptors |
title | The BET-bromodomain inhibitor JQ1 renders neuroblastoma cells more resistant to NK cell-mediated recognition and killing by downregulating ligands for NKG2D and DNAM-1 receptors |
title_full | The BET-bromodomain inhibitor JQ1 renders neuroblastoma cells more resistant to NK cell-mediated recognition and killing by downregulating ligands for NKG2D and DNAM-1 receptors |
title_fullStr | The BET-bromodomain inhibitor JQ1 renders neuroblastoma cells more resistant to NK cell-mediated recognition and killing by downregulating ligands for NKG2D and DNAM-1 receptors |
title_full_unstemmed | The BET-bromodomain inhibitor JQ1 renders neuroblastoma cells more resistant to NK cell-mediated recognition and killing by downregulating ligands for NKG2D and DNAM-1 receptors |
title_short | The BET-bromodomain inhibitor JQ1 renders neuroblastoma cells more resistant to NK cell-mediated recognition and killing by downregulating ligands for NKG2D and DNAM-1 receptors |
title_sort | bet-bromodomain inhibitor jq1 renders neuroblastoma cells more resistant to nk cell-mediated recognition and killing by downregulating ligands for nkg2d and dnam-1 receptors |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481332/ https://www.ncbi.nlm.nih.gov/pubmed/31040907 http://dx.doi.org/10.18632/oncotarget.26736 |
work_keys_str_mv | AT venezianiirene thebetbromodomaininhibitorjq1rendersneuroblastomacellsmoreresistanttonkcellmediatedrecognitionandkillingbydownregulatingligandsfornkg2danddnam1receptors AT frucidoriana thebetbromodomaininhibitorjq1rendersneuroblastomacellsmoreresistanttonkcellmediatedrecognitionandkillingbydownregulatingligandsfornkg2danddnam1receptors AT compagnonemirco thebetbromodomaininhibitorjq1rendersneuroblastomacellsmoreresistanttonkcellmediatedrecognitionandkillingbydownregulatingligandsfornkg2danddnam1receptors AT pistoiavito thebetbromodomaininhibitorjq1rendersneuroblastomacellsmoreresistanttonkcellmediatedrecognitionandkillingbydownregulatingligandsfornkg2danddnam1receptors AT rossipaolo thebetbromodomaininhibitorjq1rendersneuroblastomacellsmoreresistanttonkcellmediatedrecognitionandkillingbydownregulatingligandsfornkg2danddnam1receptors AT cifaldiloredana thebetbromodomaininhibitorjq1rendersneuroblastomacellsmoreresistanttonkcellmediatedrecognitionandkillingbydownregulatingligandsfornkg2danddnam1receptors AT venezianiirene betbromodomaininhibitorjq1rendersneuroblastomacellsmoreresistanttonkcellmediatedrecognitionandkillingbydownregulatingligandsfornkg2danddnam1receptors AT frucidoriana betbromodomaininhibitorjq1rendersneuroblastomacellsmoreresistanttonkcellmediatedrecognitionandkillingbydownregulatingligandsfornkg2danddnam1receptors AT compagnonemirco betbromodomaininhibitorjq1rendersneuroblastomacellsmoreresistanttonkcellmediatedrecognitionandkillingbydownregulatingligandsfornkg2danddnam1receptors AT pistoiavito betbromodomaininhibitorjq1rendersneuroblastomacellsmoreresistanttonkcellmediatedrecognitionandkillingbydownregulatingligandsfornkg2danddnam1receptors AT rossipaolo betbromodomaininhibitorjq1rendersneuroblastomacellsmoreresistanttonkcellmediatedrecognitionandkillingbydownregulatingligandsfornkg2danddnam1receptors AT cifaldiloredana betbromodomaininhibitorjq1rendersneuroblastomacellsmoreresistanttonkcellmediatedrecognitionandkillingbydownregulatingligandsfornkg2danddnam1receptors |